Myriad Genetics
MYGN
#6699
Rank
HK$5.14 B
Marketcap
HK$55.17
Share price
-3.27%
Change (1 day)
-56.66%
Change (1 year)

Earnings for Myriad Genetics (MYGN)

Earnings in 2025 (TTM): -HK$3.28 Billion

According to Myriad Genetics's latest financial reports the company's current earnings are HK$0.82 Billion. In 2024 the company made an earning of -HK$0.94 Billion, an increase over its 2023 earnings that were of -HK$2.02 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Myriad Genetics from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -HK$3.28 Billion249.32%
2024 -HK$0.94 Billion-53.49%
2023 -HK$2.02 Billion88.72%
2022 -HK$1.07 Billion172.08%
2021 -HK$0.4 Billion
2019 -HK$0.21 Billion-175.14%
2018 HK$0.27 B-70.81%
2017 HK$0.93 B22.22%
2016 HK$0.76 B-38.8%
2015 HK$1.24 B-6.12%
2014 HK$1.32 B-41.07%
2013 HK$2.25 B46.67%
2012 HK$1.53 B15.84%
2011 HK$1.32 B17.6%
2010 HK$1.12 B-15.96%
2009 HK$1.34 B
2007 -HK$0.33 Billion40.96%
2006 -HK$0.24 Billion
2003 -HK$0.27 Billion34.8%
2002 -HK$0.2 Billion89.21%
2001 -HK$0.11 Billion3.93%
2000 -HK$0.11 Billion21.76%
1999 -HK$82.79 Million-25.61%
1998 -HK$0.12 Billion38.83%
1997 -HK$80.16 Million-24.26%
1996 -HK$0.11 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Bio-Rad Laboratories
BIO
-HK$6.56 Billion 101.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
-HK$7.55 Billion 131.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
-HK$0.28 Billion-91.64%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$5.28 B-262.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$63.32 B-2,044.56%๐Ÿ‡บ๐Ÿ‡ธ USA